Financials

  • Market Capitalization 44.06 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-21.14
Fiyat/satışlar oranı
9 695.31

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
262
ARGX
argenx SE - American Depositary Shares
1031.66 USD+0.83%+1.04%+22.98%+44.89%63.84 B USD
291
MRNA
Moderna, Inc. - Common Stock
140.34 USD+1.70%-2.15%+155.49%+486.46%56.03 B USD
438
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
240.69 USD+1.51%+1.75%+15.69%-46.01%32.21 B USD
485
RPRX
Royalty Pharma plc - Class A Ordinary Shares
61.41 USD+0.92%+0.13%+5.77%+64.81%27.42 B USD

Haberler